Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 421
Selected: 0
NCT IDTitle
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
NCT00006357STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
NCT00006354Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
NCT00002623Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT03517137Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
NCT00003279Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00006230Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
NCT00002539Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
NCT02866370Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
NCT00003916Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
NCT02214134SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
NCT03673735Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC
NCT00838240Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia
NCT02929394Trabectedin Maintenance Post 1st-line in STS
NCT00002701Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
NCT00064181Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
NCT00002651SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
NCT01957436A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
NCT00005868Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
NCT01705561Evaluation of Attitudes About Fertility
NCT03134118Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
NCT00003979CHS 828 in Treating Patients With Solid Tumors
NCT00091156Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00028873R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy
NCT00081237OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
NCT03515993Follow-up in Gynecological Cancer Survivors
NCT01724333International Validation of the QLQ-OH17 for Oral Health
NCT02446444Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
NCT06783348Radiopharmaceutical Treatment of Advanced Kidney Cancer
NCT01819285Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
NCT00091572Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
NCT00079261Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT04128072Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
NCT00004179Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT04127110Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
NCT01476462Second Malignant Neoplasms After Childhood ALL Therapy
NCT01723969Screening Platform for Clinical Trials in Advanced Colorectal Cancer
NCT00766779HCT Versus CT in Elderly AML
NCT06990061Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study
NCT01942603Minimal SN Tumor Burden
NCT01969578Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT03784066Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
NCT04065165Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
NCT00003728Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
NCT00003938Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
NCT01524926CREATE: Cross-tumoral Phase 2 With Crizotinib
NCT00004885Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00949962Post-operative or Early Salvage XRT and ADT for High Risk PCa
NCT00060385Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma